Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
  <li>VIOL is a high-growth medical aesthetics company, pioneering the commercialization of radiofrequency (RF) microneedling technology with a strong global footprint, generating over 90% of its revenue from overseas markets.</li>
  <li>The company is strategically positioned in the rapidly expanding non-invasive aesthetic procedure market, which is projected to see a compound annual growth rate (CAGR) of 7-10% over the next decade, driven by increasing consumer demand for anti-aging and skin rejuvenation treatments.</li>
  <li>Under new professional management and private equity ownership, VIOL is focused on an aggressive growth strategy, including expanding its product portfolio into new technologies like HIFU, strengthening its global distribution network, and enhancing its R&amp;D capabilities to become a comprehensive medical aesthetics platform.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  VIOL is a high-growth medical aesthetics company, pioneering the commercialization of radiofrequency (RF) microneedling technology with a strong global footprint, generating over 90% of its revenue from overseas markets.
  The company is strategically positioned in the rapidly expanding non-invasive aesthetic procedure market, which is projected to see a compound annual growth rate (CAGR) of 7-10% over the next decade, driven by increasing consumer demand for anti-aging and skin rejuvenation treatments.
  Under new professional management and private equity ownership, VIOL is focused on an aggressive growth strategy, including expanding its product portfolio into new technologies like HIFU, strengthening its global distribution network, and enhancing its R&amp;D capabilities to become a comprehensive medical aesthetics platform.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

South Korea

VIOL Co., Ltd. manufactures and distributes medical equipment. The Company produces sylfirms, scarlets, skinstamps, and other related products. VIOL markets its products worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

VIOL (335890 KS)

Primer: VIOL (335890 KS) - Aug 2026

VIOL is a high-growth medical aesthetics company, pioneering the commercialization of radiofrequency (RF) microneedling technology with a strong...

αSK Primers

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)